Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phenotyping and Characterization of wtATTR-CM (TRACE 1) — Stella

Home/Transthyretin Amyloidosis/Phenotyping and Characterization of wtATTR-CM (TRACE 1)

View on ClinicalTrials.gov

Recruiting

Back to Transthyretin Amyloidosis trials

Phenotyping and Characterization of wtATTR-CM (TRACE 1)

Trial locations(1 site)

Denmark

Aarhus University Hospital, Aarhus, Arrhus N

Key details

Sponsor

Steen Hvitfeldt Poulsen

Collaborators

Novo Nordisk A/S

Enrollment target

~120 participants

Started

February 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.